ISSN: 1859 - 2872
Some factors related to results of treatment of ectopic pregnancy with single dose methotrexate at Hanoi Obstetrics and Gynecology Hospital
Main Article Content
Keywords
Abstract
Objective: The study aimed to find factors associated with the outcome of ectopic treatment with single-dose methotrexate. Subjects and method: A cross-sectional, retrospective descriptive study at National Hospital of Obstetrics and Gynecology. A total of 108 patients diagnosed with ectopic were treated by single-dose methotrexate between January 1, 2021 and December 31, 2021. Result: The group of patients without fluid in the pouch of Douglas was 14.4 times more likely to be successfully treated than the group of patients with the fluid (p=0.003), patients with βhCG level below 1000 (IU/l) were 8.09 times more likely to be successfully treated than patients with βhCG level higher than 1000 (IU/l) (p=0.007), patients with a fetal mass size of ≤ 1.5cm were 4.88 times more likely to be successfully treated than patients with a fetal mass size of > 1.5cm (p=0.04). Conclusion: The patients without fluid in the pouch of Douglas, the concentration of βhCG, the smaller the size of the pregnancy mass, the higher the success rate.
Article Details
References
2. Lipscomb Gary H, Norman L, and Vanessa M (2005) Comparison of single and multidose of methotrexate in medical treatment of ectopic pregnancy. Americal Journal of Obsetetrics and Gynecology: 7-1830.
3. Beguin C, Brichant G, De Landsheere L et al (2020) Use of methotrexate in the treatment of ectopic pregnancies: A retrospective single center study. Facts Views Vis Obgyn 11(4): 329-335.
4. Orozco EM, Sánchez-Durán MA, Bello-Muñoz JC, et al (2015) ß-hCG and prediction of therapeutic success in ectopic pregnancies treated with methotrexate, results from a prospective observational study. The Journal of Maternal-Fetal & Neonatal Medicine 28(6): 695-699.
5. Bonin L, Pedreiro C, Moret S et al (2017) Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: A comparative study of 400 cases. European Journal of Obstetrics & Gynecology and Reproductive Biology 208: 23-30.
6. Skubisz M, Dutton P, Duncan WC et al (2013) Using a decline in serum hCG between days 0-4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study. BMC pregnancy and childbirth 13(1): 1-5.
7. Gnisci A, Stefani L, Bottin P et al (2014) Predictive value of hemoperitoneum for outcome of methotrexate treatment in ectopic pregnancy: An observational comparative study. Ultrasound Obstet Gynecol 43(6): 698-701.
8. Lashin MEB, Alabiad MA, and Abdelsalam WA (2020) Values and predictive factors for success of methotrexate therapy in medical management of ectopic pregnancy. Zagazig University Medical Journal 26(6): 990-996.
9. Pulatoglu C, Dogan O, Basbug A et al (2018) Predictive factors of methotrexate treatment success in ectopic pregnancy: A single-center tertiary study. Northern clinics of Istanbul 5(3): 227.
Article Sidebar
